628 related articles for article (PubMed ID: 17702637)
21. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
22. Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice.
Ishida Y; Takayasu T; Kimura A; Hayashi T; Kakimoto N; Miyashita T; Kondo T
Leg Med (Tokyo); 2006 Mar; 8(2):102-9. PubMed ID: 16324872
[TBL] [Abstract][Full Text] [Related]
23. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.
Betsuyaku T; Fukuda Y; Parks WC; Shipley JM; Senior RM
Am J Pathol; 2000 Aug; 157(2):525-35. PubMed ID: 10934155
[TBL] [Abstract][Full Text] [Related]
24. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs NW; Huffnagle GB; Wilke CA; Burdick MD; Lincoln P; Evanoff H; Kunkel SL
J Immunol; 1994 Nov; 153(10):4704-12. PubMed ID: 7525712
[TBL] [Abstract][Full Text] [Related]
25. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
Manoury B; Nenan S; Leclerc O; Guenon I; Boichot E; Planquois JM; Bertrand CP; Lagente V
Respir Res; 2005 Jan; 6(1):11. PubMed ID: 15663794
[TBL] [Abstract][Full Text] [Related]
26. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
27. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
28. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Sakamoto H; Zhao LH; Jain F; Kradin R
Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
[TBL] [Abstract][Full Text] [Related]
29. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
30. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
32. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
33. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
Madtes DK; Elston AL; Kaback LA; Clark JG
Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
[TBL] [Abstract][Full Text] [Related]
34. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
35. Collagenase and gelatinase activities in bronchoalveolar lavage fluids during bleomycin-induced lung injury.
Bakowska J; Adamson IY
J Pathol; 1998 Jul; 185(3):319-23. PubMed ID: 9771487
[TBL] [Abstract][Full Text] [Related]
36. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
Hu P; Gao ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
[TBL] [Abstract][Full Text] [Related]
37. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung.
Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E
Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855
[TBL] [Abstract][Full Text] [Related]
38. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
Wang SJ; Bai W; Wang CL; Dai Z
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
[TBL] [Abstract][Full Text] [Related]
39. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effect of anti-alpha 1-antichymotrypsin serum on pulmonary fibrosis induced by phorbol myristate acetate in vivo.
Nagareda T; Tanaka A; Terada N; Imakon Y; Shiomi H; Matsubara H; Noro A; Nishizawa Y
Lab Invest; 1995 Oct; 73(4):541-6. PubMed ID: 7474926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
